State University of New York - Upstate Medical University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, State University of New York - Upstate Medical University sits in the top decile of US sponsors by registered trial count (#226 of 15,742 sponsors by registered trial count).

113 total trials 8 currently recruiting 75 completed top decile by trial count

State University of New York - Upstate Medical University: 113 sponsored US clinical trials, 8 recruiting.

State University of New York - Upstate Medical University sponsors 113 registered US clinical trials on ClinicalTrials.gov, 8 of them currently recruiting, and 75 completed. 15 of these trials are in Phase 3-4 (later-stage) and 21 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 2 trials.

Top-decile sponsor footprint

State University of New York - Upstate Medical University ranks in the top decile of sponsors by registered trial count (#226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 21/100

75 of 103 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (72.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

113 total, page 1 of 3

RECRUITING Early Phase 1

Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease

NCT06611111

RECRUITING NA

Dynamic Deconstructive Psychotherapy Versus Brief Intervention and Contact for Suicidal Adolescents and Young Adults

NCT05988489

RECRUITING Phase 1

Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches

NCT06112093

RECRUITING NA

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

NCT06006637

RECRUITING Phase 2

Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine

NCT00775476

RECRUITING

The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation

NCT05012605

RECRUITING Early Phase 1

Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

NCT02619448

RECRUITING

Evaluation and Optimization of Ultrasound and/or MRI Hardware and Software

NCT00640107

NOT YET RECRUITING Early Phase 1

Pharmacokinetic (PK) Study of Tafenoquine in Healthy Adults

NCT07373743

NOT YET RECRUITING

Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay

NCT07220031

COMPLETED Phase 1

Homologous Re-infection With Dengue 1 or Dengue 3

NCT05967455

COMPLETED Phase 4

Does a Soft Drink Mixture Improve Tolerance of Activated Charcoal in the Adult Poisoned Patient Without Affecting Efficacy

NCT06219967

COMPLETED NA

BIG for Life: a Pilot Study

NCT04090476

COMPLETED Early Phase 1

Marcaine Post-Operative Pain Study

NCT04494880

COMPLETED NA

The SPROUT (Pilot) Project

NCT05394883

COMPLETED Phase 1

Dengue 3 Human Infection Model (DENV-3)

NCT04298138

COMPLETED

Bright Light Therapy as Augmentation of Depressive Symptoms on Acute Psychiatric Floor

NCT04385394

COMPLETED NA

Behavioral Economics and Communication

NCT05918393

COMPLETED Phase 1

Expansion of a Dengue-1 Live Virus Human Challenge

NCT03869060

TERMINATED NA

UltraWee: Ultrasound Bladder Stimulation

NCT03801720

COMPLETED Phase 4

Onabotulinumtoxin Type A Reconstitution With Preserved Versus Preservative-free Saline in Chronic Migraine.

NCT03698409

COMPLETED

Participant(s) With Autism and High Pain Tolerance Treated With High Dose Naltrexone

NCT05100563

COMPLETED

Mindful Melody: Feasibility of Implementing Music Listening on an Inpatient Psychiatric Unit and Its Relation to the Use of As Needed Medications for Acute Agitation

NCT04514432

COMPLETED Phase 2

Personalized Antiplatelet Secondary Stroke PRevenTion

NCT03979781

COMPLETED NA

A Usability Assessment of Naloxone Administration by Untrained Community Members

NCT04025671

TERMINATED NA

Management of Pediatric Chronic Rhinosinusitis in Asthmatic Children

NCT03336671

COMPLETED NA

Beer for Endurance Exercise Recovery

NCT03032445

COMPLETED Phase 4

Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.

NCT02564471

COMPLETED

Visual Examination of Airway Via Flexible Fiberoptic Scope After Cervical Spine Surgery

NCT06230315

COMPLETED NA

Analysis of Bone Micro-Architecture as a Clinical Biomarker for Image-Based Fracture Risk Estimation.

NCT03463850

COMPLETED NA

The Feasibility of Using Neuroscience Education in Adults Over 65 Years Old With Chronic Low Back and/or Lower Extremity Pain

NCT02449876

COMPLETED

A Salivary miRNA Diagnostic Test for Autism

NCT02832557

COMPLETED

Effect of Duration of Exposure of Anesthesia With Sevoflurane on Emergence Delirium

NCT02509221

COMPLETED Phase 4

Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis

NCT02374814

TERMINATED Phase 1

Rivaroxaban Effects in Subjects Who Have Undergone Gastric Bypass Surgery

NCT02058199

COMPLETED

Longitudinal Family/Molecular Genetic Study to Validate Research Domain Criteria

NCT02415647

COMPLETED NA

Prone Whole-Breast RadiationTherapy Versus Supine Whole-Breast Radiation Therapy Imaging

NCT03037723

COMPLETED

Hyperbaric Oxygen and Its Effect on Radiation Induced Long Term Side Effects

NCT02450305

COMPLETED

Exosomal MicroRNA Expression in Children With Autism Spectrum Disorder

NCT01749670

TERMINATED Early Phase 1

Amiloride Hydrochloride as an Effective Treatment for ADHD

NCT01733680

TERMINATED

In Vivo Raman Spectroscopy of Human Capillary Beds

NCT02333136

COMPLETED Early Phase 1

Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer

NCT01738815

TERMINATED

Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm

NCT01801488

COMPLETED

Myocardial Perfusion Study to Detect Coronary Microvascular Abnormality in Diabetic Patients With Nonfatal Myocardial Infarction

NCT01749683

TERMINATED

Event Related Potentials in Borderline Personality Disorder and Major Depression

NCT01469663

TERMINATED

Multi-Compression Spot Mammography

NCT01372215

COMPLETED

Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage

NCT01799018

COMPLETED Phase 1

Creativity Group for Borderline Personality Disorder

NCT01343550

TERMINATED Early Phase 1

Continuous Neurophysiological Monitoring Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Subjects

NCT01343537

COMPLETED

Microbes and Bariatric Surgery

NCT01130207

Page 1 of 3 Next →

Phase Distribution

PhaseTrial count
Phase 1 16
Phase 2 5
Phase 3 2
Phase 4 13

What is open in the State University of New York - Upstate Medical University pipeline

8 recruiting of 113 indexed (7% open); 75 completed (66%).

Phase mix: 15 late (III/IV) vs 21 early (I/II) (balanced across stages).

Top condition: Stroke (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

State University of New York - Upstate Medical University: open-pipeline peers nationwide

Peers matched on 113 registered trials and 7% open enrollment, not the therapeutic-area sidebar.

State University of New York - Upstate Medical University sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 0%5%10%15%20%25% Total trials Recruiting share State University of New York - Upstate Medical UniversityMedstar Health Research InstituteMedtronic Cardiac Rhythm and Heart FailureZimmer BiometRockefeller UniversityBristol-Myers SquibbCarol Fabian, MDCelldex TherapeuticsKaiser Permanente
State University of New York - Upstate Medical University sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

State University of New York - Upstate Medical University sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 113 trials (± recruiting share)

Sponsors near 7% open enrollment (± trial volume)

What to do with this State University of New York - Upstate Medical University page

113 registered trials is a research-attention snapshot, not an endorsement of State University of New York - Upstate Medical University or any single study.

  • 8 of State University of New York - Upstate Medical University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition State University of New York - Upstate Medical University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

State University of New York - Upstate Medical University pipeline card: 113 registered trials from official public datasets.Report a data error.